1837 Partners L.P.
CIK 0001363397 Name as filed on the most recent filing
Filed as 1837 Partners L.P. (22)
61 transaction lines · from 22 filings · filed 2006-09-26 to 2007-07-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2007-07-18 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 25,140 disposed | 5.43 | 136,510.20 | Form 4, filing 0001363399-07-000022 | |
| 2007-07-18 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 6,330 disposed | 5.43 | 34,371.90 | Form 4, filing 0001363399-07-000022 | |
| 2007-07-18 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 6,030 disposed | 5.43 | 32,742.90 | Form 4, filing 0001363399-07-000022 | |
| 2007-07-17 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 2,382 disposed | 5.33 | 12,696.06 | Form 4, filing 0001363399-07-000021 | |
| 2007-07-17 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 600 disposed | 5.33 | 3,198.00 | Form 4, filing 0001363399-07-000021 | |
| 2007-07-17 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 570 disposed | 5.33 | 3,038.10 | Form 4, filing 0001363399-07-000021 | |
| 2007-07-16 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 1,680 disposed | 5.33 | 8,954.40 | Form 4, filing 0001363399-07-000021 | |
| 2007-07-16 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 420 disposed | 5.33 | 2,238.60 | Form 4, filing 0001363399-07-000021 | |
| 2007-07-16 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 400 disposed | 5.33 | 2,132.00 | Form 4, filing 0001363399-07-000021 | |
| 2007-07-11 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 12,792 disposed | 4.66 | 59,610.72 | Form 4, filing 0001363399-07-000020 | |
| 2007-07-11 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 12,408 disposed | 4.67 | 57,945.36 | Form 4, filing 0001363399-07-000020 | |
| 2007-07-11 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 7,208 disposed | 4.66 | 33,589.28 | Form 4, filing 0001363399-07-000020 | |
| 2007-07-11 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 6,992 disposed | 4.67 | 32,652.64 | Form 4, filing 0001363399-07-000020 | |
| 2007-07-10 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 6,910 disposed | 4.58 | 31,647.80 | Form 4, filing 0001363399-07-000019 | |
| 2007-07-10 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 1,740 disposed | 4.58 | 7,969.20 | Form 4, filing 0001363399-07-000019 | |
| 2007-07-10 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 1,650 disposed | 4.58 | 7,557.00 | Form 4, filing 0001363399-07-000019 | |
| 2007-07-09 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 1,540 disposed | 4.65 | 7,161.00 | Form 4, filing 0001363399-07-000017 | |
| 2007-07-09 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 390 disposed | 4.65 | 1,813.50 | Form 4, filing 0001363399-07-000017 | |
| 2007-07-09 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 370 disposed | 4.65 | 1,720.50 | Form 4, filing 0001363399-07-000017 | |
| 2007-07-06 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 2,700 disposed | 4.64 | 12,528.00 | Form 4, filing 0001363399-07-000018 | |
| 2007-07-06 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 4,800 disposed | 4.64 | 22,272.00 | Form 4, filing 0001363399-07-000018 | |
| 2007-07-06 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 4,800 disposed | 4.64 | 22,272.00 | Form 4, filing 0001363399-07-000016 | |
| 2007-07-06 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 2,700 disposed | 4.64 | 12,528.00 | Form 4, filing 0001363399-07-000016 | |
| 2007-07-05 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 3,812 disposed | 4.65 | 17,725.80 | Form 4, filing 0001363399-07-000015 | |
| 2007-07-05 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 2,140 disposed | 4.65 | 9,951.00 | Form 4, filing 0001363399-07-000015 | |
| 2007-07-02 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 71,200 disposed | 4.56 | 324,672.00 | Form 4, filing 0001363399-07-000014 | |
| 2007-07-02 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 49,700 acquired | 4.59 | 228,123.00 | Form 4, filing 0001363399-07-000014 | |
| 2007-07-02 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 21,500 acquired | 4.59 | 98,685.00 | Form 4, filing 0001363399-07-000014 | |
| 2007-06-13 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 4,500 disposed | 4.74 | 21,330.00 | Form 4, filing 0001363399-07-000013 | |
| 2007-06-13 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 1,800 disposed | 4.73 | 8,514.00 | Form 4, filing 0001363399-07-000013 | |
| 2007-06-13 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 6,300 acquired | 4.76 | 29,988.00 | Form 4, filing 0001363399-07-000013 | |
| 2007-06-01 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 75,800 disposed | 4.65 | 352,470.00 | Form 4, filing 0001363399-07-000012 | |
| 2007-06-01 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 60,000 acquired | 4.67 | 280,200.00 | Form 4, filing 0001363399-07-000012 | |
| 2007-06-01 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 15,800 acquired | 4.67 | 73,786.00 | Form 4, filing 0001363399-07-000012 | |
| 2007-05-15 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 3,000 acquired | 4.51 | 13,530.00 | Form 4, filing 0001363399-07-000011 | |
| 2007-05-11 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 4,970 acquired | 4.40 | 21,868.00 | Form 4, filing 0001363399-07-000010 | |
| 2007-05-09 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 23,692 disposed | 4.41 | 104,481.72 | Form 4, filing 0001363399-07-000009 | |
| 2007-05-09 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 23,692 acquired | 4.44 | 105,192.48 | Form 4, filing 0001363399-07-000009 | |
| 2007-05-08 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 6,000 acquired | 4.47 | 26,820.00 | Form 4, filing 0001363399-07-000008 | |
| 2007-05-07 |
AspenBio Pharma, Inc. APNB |
S, Open-market sale | 1,900 disposed | 4.58 | 8,702.00 | Form 4, filing 0001363399-07-000007 | |
| 2007-05-07 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 1,900 acquired | 4.58 | 8,702.00 | Form 4, filing 0001363399-07-000007 | |
| 2007-05-03 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 68,370 acquired | 4.56 | 311,767.20 | Form 4, filing 0001363399-07-000006 | |
| 2007-05-03 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 16,210 acquired | 4.56 | 73,917.60 | Form 4, filing 0001363399-07-000006 | |
| 2007-05-03 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 15,420 acquired | 4.56 | 70,315.20 | Form 4, filing 0001363399-07-000006 | |
| 2007-05-03 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 7,140 acquired | 4.35 | 31,059.00 | Form 4, filing 0001363399-07-000006 | |
| 2007-05-03 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 1,694 acquired | 4.35 | 7,368.90 | Form 4, filing 0001363399-07-000006 | |
| 2007-05-03 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 1,610 acquired | 4.35 | 7,003.50 | Form 4, filing 0001363399-07-000006 | |
| 2007-05-02 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 20,510 acquired | 4.29 | 87,987.90 | Form 4, filing 0001363399-07-000005 | |
| 2007-05-02 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 4,860 acquired | 4.29 | 20,849.40 | Form 4, filing 0001363399-07-000005 | |
| 2007-05-02 |
AspenBio Pharma, Inc. APNB |
P, Open-market purchase | 4,630 acquired | 4.29 | 19,862.70 | Form 4, filing 0001363399-07-000005 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. 1837 Partners L.P., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001363397
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6